WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004098586) USE OF PHENOXYACETIC ACID DERIVATIVES FOR TREATING HYPERACTIVE BLADDER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/098586    International Application No.:    PCT/JP2004/004048
Publication Date: 18.11.2004 International Filing Date: 24.03.2004
IPC:
A61K 31/191 (2006.01), A61K 31/192 (2006.01), A61K 31/195 (2006.01), A61K 31/216 (2006.01), A61K 31/24 (2006.01)
Applicants: KISSEI PHARMACEUTICAL CO., LTD. [JP/JP]; 19-48, Yoshino, Matsumoto-shi, Nagano 399-8710 (JP) (For All Designated States Except US).
YAMAZAKI, Yoshinobu [JP/JP]; (JP) (For US Only).
KOJIMA, Masami [JP/JP]; (JP) (For US Only)
Inventors: YAMAZAKI, Yoshinobu; (JP).
KOJIMA, Masami; (JP)
Priority Data:
103 20 084.3 05.05.2003 DE
103 23 837.9 23.05.2003 DE
Title (EN) USE OF PHENOXYACETIC ACID DERIVATIVES FOR TREATING HYPERACTIVE BLADDER
(FR) UTILISATION DE DERIVES DE L'ACIDE PHENOXYACETIQUE EN VUE DU TRAITEMENT D'UNE VESSIE HYPERACTIVE
Abstract: front page image
(EN)The present invention relates to a new field of indication for phenoxyacetic acid derivatives as described in European Patent Application EP 1095932. It has now been found that the compounds described therein are suitable for the preparation of a medicament for treating hyperactive bladder (overactive bladder). Accordingly, by means of these active substances, a method is provided for treating this urological syndrome.
(FR)La présente invention se rapporte à un nouveau domaine d'indication pour des dérivés de l'acide phénoxyacétique comme décrit dans la demande de brevet européen EP 1095932. Il a été démontré que les composés décrit dans le brevet susmentionné se prêtent à la préparation d'un médicament traitant la vessie hyperactive. Dans cette même optique, au moyen de ces substances actives, on prévoit une méthode de traitement de ce syndrome urologique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)